You searched for "ARN"
Effect of long-term RGP-CL wear on keratoconus progression
This is a retrospective study between April and December 2017, of 22 rigid gas-permeable contact lens (RGP-CL) patients (31 eyes) and 15 non-CL patients (20 eyes) who fulfilled the criteria of: 1) >3 years follow-up and 2) Scheimpflug-based corneal imaging...New UK study finds widespread hidden sensory loss
One in four over-50s has vision impairment and three quarters have some hearing loss. Groundbreaking research involving eye tests and hearing examinations with more than 500 over-50’s – the first of its kind in the UK – has revealed widespread...OSA regulatory advice baton moves to new expert
The OSA’s regulatory advice service – a key element of membership for many optical businesses – is moving to safe new hands as Ann Blackmore retires after six years at the helm. Ann’s extensive knowledge of the optical landscape, both...Conference Preview: OOC 2025
Leading us into July this year will be the 108th Oxford Ophthalmological Congress (OOC), the longest-standing congress dedicated to ophthalmology in the UK. This year, the OOC has attracted the largest number of abstracts it has ever seen in its...Retina World Congress 2025
As one of the largest retina meetings in the world, Retina World Congress is leading the advancement of science in retina. Its annual meeting brings together retina specialists from every continent to achieve a global scientific and clinical exchange in...
RPE tears after intravitreal Lucentis
The current hypothesis regarding retinal pigment epithelium (RPE) tears is the contraction and fibrosis in choroidal neovascularisation (CNV) tissue after anti-VEGF therapy can induce rips in the overlying RPE. This South Korean study aimed to identify the association between RPE...
Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO
This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...
Intravitreal ranibizumab for the treatment of myopic CNV
The authors conducted a prospective study. Sixty-four patients (65 eyes) attended the 12-month follow-up examination. The mean patient age was 47.8 years. Fifty-five patients (86.0%) were females. All patients had pathologic myopia (a spherical equivalent of more than − 6.0...
Intravitreal aflibercept for retinal angiomatous proliferation (RAP)
In this prospective study the authors present the visual and anatomical outcome of patients with RAP lesions who were treated with intravitreal aflibercept. The study cohort of 46 patients reached study completion at week 96. They were all Caucasians, with...
